ATE161257T1 - Azolylamin-derivat - Google Patents

Azolylamin-derivat

Info

Publication number
ATE161257T1
ATE161257T1 AT94914585T AT94914585T ATE161257T1 AT E161257 T1 ATE161257 T1 AT E161257T1 AT 94914585 T AT94914585 T AT 94914585T AT 94914585 T AT94914585 T AT 94914585T AT E161257 T1 ATE161257 T1 AT E161257T1
Authority
AT
Austria
Prior art keywords
acid
addition salt
azolylamine
derivative
azolylamine derivative
Prior art date
Application number
AT94914585T
Other languages
English (en)
Inventor
Takanobu Naito
Haruhito Kobayashi
Hironobu Ogura
Kiyoshi Nagai
Tokiko Nishida
Tadashi Arika
Mamoru Yokoo
Satoko Shusse
Original Assignee
Kaken Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharma Co Ltd filed Critical Kaken Pharma Co Ltd
Application granted granted Critical
Publication of ATE161257T1 publication Critical patent/ATE161257T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymerization Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94914585T 1993-05-10 1994-05-02 Azolylamin-derivat ATE161257T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13293193 1993-05-10

Publications (1)

Publication Number Publication Date
ATE161257T1 true ATE161257T1 (de) 1998-01-15

Family

ID=15092851

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94914585T ATE161257T1 (de) 1993-05-10 1994-05-02 Azolylamin-derivat

Country Status (15)

Country Link
US (3) US5620994A (de)
EP (1) EP0698606B1 (de)
KR (1) KR100339166B1 (de)
CN (1) CN1046278C (de)
AT (1) ATE161257T1 (de)
AU (1) AU685116B2 (de)
CA (1) CA2162463C (de)
DE (1) DE69407409T2 (de)
DK (1) DK0698606T3 (de)
ES (1) ES2110749T3 (de)
GR (1) GR3025715T3 (de)
HU (1) HU225416B1 (de)
TW (1) TW325473B (de)
UA (1) UA41365C2 (de)
WO (1) WO1994026734A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA41365C2 (uk) * 1993-05-10 2001-09-17 Какєн Фармасьютікал Ко., Лтд Похідні азоліламіну та фунгіцидний засіб на їх основі
CN1125814C (zh) * 1995-09-28 2003-10-29 科研制药株式会社 4-亚甲基哌啶的制备方法
EP1205559B1 (de) * 1999-07-28 2009-06-24 Kaken Pharmaceutical Co., Ltd. Verfahren zum nachweis pathogener mikroorganismen und antimikrobieller mittel, verfahren zum nachweis der arzneimittelwirkung antimikrobieller mittel und antimikrobielle mittel
US20100080869A1 (en) * 2004-05-25 2010-04-01 Watson James B Live Bacteria product
US20090162419A1 (en) * 2004-05-25 2009-06-25 Watson James B Live bacteria product
US20090162481A1 (en) * 2004-05-25 2009-06-25 Watson James B Live bacteria product
WO2007101204A1 (en) * 2006-02-27 2007-09-07 Alcon Research, Ltd. Method of treating glaucoma
DE602007009574D1 (de) * 2006-12-28 2010-11-11 Kaken Pharma Co Ltd Gelzusammensetzung zur behandlung von mykose
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
BR112013004827B1 (pt) * 2010-08-31 2020-03-31 Kaken Pharmaceutical Co., Ltd. Processo para a produção de derivados de 1-triazol-2-butanol
CN105683184B (zh) 2013-10-03 2019-05-10 道尔医药科学公司 稳定的艾菲康唑组合物
EP3071295A4 (de) 2013-11-22 2017-05-31 Dow Pharmaceutical Sciences, Inc. Antiinfektiöse verfahren, zusammensetzungen und vorrichtungen
CN104292214B (zh) * 2014-09-24 2017-04-05 南京华威医药科技开发有限公司 艾氟康唑及其中间体的合成方法
CN104327047B (zh) * 2014-10-17 2016-04-06 苏州明锐医药科技有限公司 艾菲康唑的制备方法
US9617241B2 (en) 2014-11-23 2017-04-11 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of efinaconazole
AU2015379251A1 (en) * 2015-01-20 2017-07-27 Wavelength Enterprises Ltd Crystalline forms of efinaconazole
ITUB20150417A1 (it) 2015-05-08 2016-11-08 Dipharma Francis Srl Procedimento per la preparazione di composti piperidinici
WO2016181306A1 (en) * 2015-05-12 2016-11-17 Lupin Limited Process for the preparation of efinaconazole
EP3112360A1 (de) * 2015-06-29 2017-01-04 Dipharma Francis S.r.l. Verfahren zur herstellung von efinaconazol
CN106565672A (zh) * 2015-10-08 2017-04-19 中美华世通生物医药科技(武汉)有限公司 制备艾氟康唑的方法
US20170129874A1 (en) * 2015-11-10 2017-05-11 Virupaksha Organics Limited Novel improved process for preparing a triazole antifungal agent
CN106810534A (zh) * 2015-11-30 2017-06-09 中美华世通生物医药科技(武汉)有限公司 艾氟康唑晶型及其制备方法
CN106928186A (zh) * 2015-12-29 2017-07-07 中美华世通生物医药科技(武汉)有限公司 化合物及其制备方法和用途
ITUB20159795A1 (it) 2015-12-30 2017-06-30 Procos Spa Processo per la sintesi di efinaconazolo
ITUA20162545A1 (it) 2016-04-13 2017-10-13 Laboratorio Chimico Int S P A Procedimento per la preparazione di intermedi utili nella sintesi di farmaci
US11185548B2 (en) 2016-12-23 2021-11-30 Helmholtz Zentrum Munchen—Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases
IT201700048270A1 (it) 2017-05-04 2018-11-04 Seegpharm Sa Procedimento per la preparazione di un derivato azolico.
JP7203612B2 (ja) * 2017-05-19 2023-01-13 科研製薬株式会社 エフィナコナゾールの製造及び精製方法
SG11201911637QA (en) 2017-08-10 2020-01-30 Sumitomo Chemical Co Process for producing epoxy alcohol compound
CN112805271A (zh) * 2018-12-29 2021-05-14 威智医药有限公司 一种艾氟康唑的制备方法
JP2021054781A (ja) 2019-09-26 2021-04-08 デボン エルエス,リミテッド 共結晶形エフィナコナゾール、及びその製造方法
KR102181155B1 (ko) 2019-09-26 2020-11-20 대봉엘에스 주식회사 이온성 액체를 매개로 한 에피나코나졸의 신규 제조방법
KR102301743B1 (ko) 2020-12-29 2021-09-13 대봉엘에스 주식회사 에피나코나졸 경구용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU187399B (en) * 1980-12-24 1985-12-28 Sumitomo Chemical Co Process for preparing imidazolyl-propanol derivatives
US4507484A (en) * 1982-07-24 1985-03-26 Pfizer Inc. Triazole antifungal agents
GB8412750D0 (en) * 1984-05-18 1984-06-27 Ici Plc Heterocyclic compounds
UA41365C2 (uk) * 1993-05-10 2001-09-17 Какєн Фармасьютікал Ко., Лтд Похідні азоліламіну та фунгіцидний засіб на їх основі

Also Published As

Publication number Publication date
HU9503217D0 (en) 1996-01-29
US5962476A (en) 1999-10-05
DE69407409T2 (de) 1998-04-09
KR100339166B1 (ko) 2004-04-30
CA2162463A1 (en) 1994-11-24
CN1046278C (zh) 1999-11-10
CN1122598A (zh) 1996-05-15
US5620994A (en) 1997-04-15
US5716969A (en) 1998-02-10
HUT75031A (en) 1997-03-28
AU685116B2 (en) 1998-01-15
EP0698606B1 (de) 1997-12-17
EP0698606A4 (de) 1996-04-10
AU6689694A (en) 1994-12-12
UA41365C2 (uk) 2001-09-17
CA2162463C (en) 2006-01-03
DE69407409D1 (de) 1998-01-29
TW325473B (en) 1998-01-21
GR3025715T3 (en) 1998-03-31
DK0698606T3 (da) 1998-08-24
EP0698606A1 (de) 1996-02-28
ES2110749T3 (es) 1998-02-16
HU225416B1 (en) 2006-11-28
WO1994026734A1 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
DE69407409D1 (de) Azolylamin-derivat
AU5777490A (en) Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
BR9407169A (pt) Derivados de pirazol
AU9281198A (en) Benzofuran derivatives
ZA916268B (en) Tricyclic compound or salts thereof,method for producing the same and antimicrobial agent containing the same
DK0695755T3 (da) Pyrrolocarbazoler
NO944371L (no) Kjemisk forbindelse med blodplateaggregeringsinhibiotoraktivitet
ATE156486T1 (de) Fungizide 3,4-diaryl-(5h)-furan-2-onederivate
DE69423339D1 (de) Epoxycyclohexendionderivat
FI952420A (fi) Glukopyranosidibentsotiofeenit
DK0676399T3 (da) Methotrexaderivater
ITMI930819A1 (it) Derivati eterobiciclici ad attivita' fungicida
EP0994111A4 (de) Tetrahydrofuranderivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification